AMIFOSTINE (Sun Pharmaceutical Industries Limited)


Welcome to the PulseAid listing for the AMIFOSTINE drug offered from Sun Pharmaceutical Industries Limited. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sun Pharmaceutical Industries Limited
NON-PROPRIETARY NAME: AMIFOSTINE
SUBSTANCE NAME: AMIFOSTINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2008-03-14
END MARKETING DATE: 0000-00-00


AMIFOSTINE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAMIFOSTINE from Sun Pharmaceutical Industries Limited
LABELER NAME: Sun Pharmaceutical Industries Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/mL)
START MARKETING DATE: 2008-03-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62756-581_2a527ed0-3af2-41eb-9e8f-5b4783b37259
PRODUCT NDC: 62756-581
APPLICATION NUMBER: ANDA077126

Other AMIFOSTINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Bedford Laboratoriesamifostine
Cumberland Pharmaceuticals Inc.Ethyol
Sun Pharmaceutical Industries LimitedAMIFOSTINE